BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 20858706)

  • 21. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding.
    Fletcher PJ; Grottick AJ; Higgins GA
    Neuropsychopharmacology; 2002 Oct; 27(4):576-86. PubMed ID: 12377394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Directly Observable Behavioral Effects of Lorcaserin in Rats.
    Serafine KM; Rice KC; France CP
    J Pharmacol Exp Ther; 2015 Dec; 355(3):381-5. PubMed ID: 26384326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats.
    Burton CL; Rizos Z; Diwan M; Nobrega JN; Fletcher PJ
    Behav Brain Res; 2013 Mar; 240():171-81. PubMed ID: 23201361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice.
    Dougherty JP; Aloyo VJ
    Psychopharmacology (Berl); 2011 Jun; 215(3):581-93. PubMed ID: 21340474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice.
    Egashira N; Okuno R; Shirakawa A; Nagao M; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    Biol Pharm Bull; 2012; 35(3):376-9. PubMed ID: 22382324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
    Schindler EA; Harvey JA; Aloyo VJ
    Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.
    Elmore JS; Decker AM; Sulima A; Rice KC; Partilla JS; Blough BE; Baumann MH
    Neuropharmacology; 2018 Nov; 142():240-250. PubMed ID: 29501528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist.
    Kimura Y; Hatanaka K; Naitou Y; Maeno K; Shimada I; Koakutsu A; Wanibuchi F; Yamaguchi T
    Eur J Pharmacol; 2004 Jan; 483(1):37-43. PubMed ID: 14709324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced cortical serotonin 5-HT
    Mora S; Merchán A; Vilchez O; Aznar S; Klein AB; Ultved L; Campa L; Suñol C; Flores P; Moreno M
    Neuropharmacology; 2018 Dec; 143():10-19. PubMed ID: 30201211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
    Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
    Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of acute systemic administration of serotonin2A/C receptor ligands in a delay-based decision-making task in rats.
    Hadamitzky M; Feja M; Becker T; Koch M
    Behav Pharmacol; 2009 Sep; 20(5-6):415-23. PubMed ID: 19730369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
    Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
    Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.
    Hemrick-Luecke SK; Evans DC
    Neuropharmacology; 2002 Feb; 42(2):162-9. PubMed ID: 11804612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic fluvoxamine treatment changes 5-HT(2A/2C) receptor-mediated behavior in olfactory bulbectomized mice.
    Oba A; Nakagawasai O; Onogi H; Nemoto W; Yaoita F; Arai Y; Tan-No K; Tadano T
    Life Sci; 2013 Feb; 92(2):119-24. PubMed ID: 23159642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
    Willins DL; Meltzer HY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):699-706. PubMed ID: 9262333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
    Canal CE; Morgan D; Felsing D; Kondabolu K; Rowland NE; Robertson KL; Sakhuja R; Booth RG
    J Pharmacol Exp Ther; 2014 May; 349(2):310-8. PubMed ID: 24563531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands.
    Canal CE; Cordova-Sintjago T; Liu Y; Kim MS; Morgan D; Booth RG
    J Pharmacol Exp Ther; 2013 Dec; 347(3):705-16. PubMed ID: 24080681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2,5-Dimethoxy-4-iodoamphetamine (DOI) inhibits Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
    Egashira N; Koushi E; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    J Pharmacol Sci; 2007 Dec; 105(4):361-6. PubMed ID: 18057774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen.
    Pockros LA; Pentkowski NS; Conway SM; Ullman TE; Zwick KR; Neisewander JL
    Synapse; 2012 Dec; 66(12):989-1001. PubMed ID: 22886755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.